首页> 外文期刊>Journal of Clinical Pathology >Prognostic value of activated Akt expression in oral squamous cell carcinoma.
【24h】

Prognostic value of activated Akt expression in oral squamous cell carcinoma.

机译:活化的Akt表达在口腔鳞状细胞癌中的预后价值。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Akt is a serine/threonine kinase that plays an important role in tumorigenesis and influences prognosis in several cancers. However, its importance in oral squamous cell carcinomas (OSCC) has not been elucidated. AIM: To investigate the association between the expression of activated Akt, clinicopathological factors, and E-cadherin, PCNA (proliferating cell nuclear antigen), and VEGF (vascular endothelial growth factor) expression to verify the validity of Akt as a prognostic factor in OSCC. METHODS: Phosphorylated Akt (p-Akt), E-cadherin, PCNA, and VEGF expression were assessed immunohistochemically in 84 OSCCs. The results were analysed in relation to clinicopathological factors. RESULTS: p-Akt was expressed in 29 cases. It was significantly correlated with lymph node metastasis, TNM stage, and E-cadherin expression. Univariate analysis showed that p-Akt expression, E-cadherin expression, PCNA expression, differentiation, tumour size, lymph node metastasis, TNM stage, and recurrence correlated with prognosis. Multivariate analysis showed that p-Akt expression is an independent prognostic factor in patients with OSCC. CONCLUSIONS: This study revealed that Akt activation is a significant prognostic indicator for OSCC and is correlated with E-cadherin expression. The inhibition of Akt is a possible molecular approach to the treatment of OSCC.
机译:背景:Akt是一种丝氨酸/苏氨酸激酶,在肿瘤发生中起重要作用,并影响多种癌症的预后。但是,其在口腔鳞状细胞癌(OSCC)中的重要性尚未阐明。目的:探讨活化的Akt,临床病理因素与E-钙粘蛋白,PCNA(增殖细胞核抗原)和VEGF(血管内皮生长因子)的表达之间的关系,以验证Akt作为OSCC预后因素的有效性。方法:采用免疫组织化学方法对84例OSCC中的磷酸化Akt(p-Akt),E-cadherin,PCNA和VEGF表达进行了评估。分析了与临床病理因素相关的结果。结果:p-Akt表达29例。它与淋巴结转移,TNM分期和E-cadherin表达显着相关。单因素分析表明,p-Akt表达,E-钙黏着蛋白表达,PCNA表达,分化,肿瘤大小,淋巴结转移,TNM分期和复发与预后相关。多因素分析表明,p-Akt表达是OSCC患者的独立预后因素。结论:这项研究表明,Akt激活是OSCC的重要预后指标,并且与E-钙粘蛋白表达有关。抑制Akt是治疗OSCC的一种可能的分子方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号